ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - glucose hydrous 1.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.

ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - glucose hydrous 2.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - arginine; calcium chloride dihydrate; glycine; histidine; isoleucine; l- alanine; leucine; lysine hydrochloride; magnesium chloride hexahydrate; methionine; phenylalanine; proline; serine; sodium (s) - lactate; sodium chloride; threonine; tryptophan; tyrosine; valine - תמיסה לדיאליזה פריטוניאלית - tyrosine 0.3 g/l; tryptophan 0.27 g/l; phenylalanine 0.57 g/l; threonine 0.646 g/l; serine 0.51 g/l; proline 0595 g/l; glycine 0.51 g/l; l- alanine 0.951 g/l; valine 1.393 g/l; methionine 0.85 g/l; isoleucine 0.85 g/l; leucine 1.02 g/l; histidine 0.714 g/l; arginine 1.071 g/l; sodium chloride 5.38 g/l; lysine hydrochloride 0.955 g/l; calcium chloride dihydrate 0.184 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium (s) - lactate 4.480 g/l - combinations of electrolytes - combinations of electrolytes - nutritional supplement for malnourished renal failure patients (albumin concentration lower then 35 g/liter) being maintained on peritoneal dialysis.

ישראל - עברית - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride dihydrate; glucose as monohydrate; magnesium chloride hexahydrate; sodium carbonate hydrogen; sodium chloride - תמיסה להמודיאליזה\המופילטרציה - sodium chloride 6.136 g/l; calcium chloride dihydrate 0.2205 g/l; sodium carbonate hydrogen 2.940 g/l; glucose as monohydrate 1 g/l; magnesium chloride hexahydrate 0.1017 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with acute renal failure, requiring continuous haemofiltration.

ישראל - עברית - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride dihydrate; glucose as monohydrate; magnesium chloride hexahydrate; potassium chloride; sodium carbonate hydrogen; sodium chloride - תמיסה להמודיאליזה\המופילטרציה - glucose as monohydrate 1 g/l; magnesium chloride hexahydrate 0.1017 g/l; potassium chloride 0.2982 g/l; calcium chloride dihydrate 0.2205 g/l; sodium carbonate hydrogen 2.940 g/l; sodium chloride 6.136 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with acute renal failure, requiring continuous haemofiltration.

ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - glucose hydrous 4.25 g / 100 ml; magnesium chloride 5.08 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; calcium chloride 18.3 mg / 100 ml - electrolytes in combination with other drugs - electrolytes in combination with other drugs - for use in chronic renal failure patient being maintained in peritoneal dialysis.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליות מצופות פילם - atorvastatin as calcium 40 mg - atorvastatin - atorvastatin - lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. lipitor is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליות מצופות פילם - atorvastatin as calcium 80 mg - atorvastatin - atorvastatin - lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. lipitor is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליות מצופות פילם - atorvastatin as calcium 80 mg - atorvastatin - atorvastatin - lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. lipitor is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - atorvastatin as calcium - טבליות מצופות פילם - atorvastatin as calcium 10 mg - atorvastatin - atorvastatin - lipitor is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. lipitor is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190